Læknablaðið : fylgirit - 05.01.2015, Qupperneq 50

Læknablaðið : fylgirit - 05.01.2015, Qupperneq 50
X V I I V Í S I N D A R Á Ð S T E F N A H Í F Y L G I R I T 8 2 50 LÆKNAblaðið/Fylgirit 82 2015/101 og fannst mikilvægt að geta haft áhrif á hvað væri í matinn. Jafnframt kvörtuðu þau yfir löngum biðröðum og að of lítill tími væri gefinn til að matast. Ályktanir: Börnin eru notendur skólamötuneytanna og því er mikilvægt að hlusta á raddir þeirra í áframhaldandi þróun skólamötuneyta og styðja þannig við heilsu og vellíðan. E 136 Mental health effects of the Eyjafjallajökull volcano eruption: A population-based study Ólöf Sunna Gissurardóttir1, Guðrún Pétursdóttir2, Edda Björk Þórðardóttir1, Arna Hauksdóttir1 1Centre of Public health Sciences, University of Iceland, 2Institute for Sustainability Studies osg6@hi.is Introduction: In April 2010, the Eyjafjallajökull volcano in Southern Iceland erupted, directly affecting more than 2000 residents of the area closest to the volcano. The general aim of this study is to examine the mental health effects of the Eyjafjallajökull volcano eruption on nearby residents. Methods and data: This study was conducted 6-9 months after the Eyjafjallajökull eruption in 2010 on 1146 individuals from the exposed area and 510 individuals from a non exposed area who answered a ques- tionnaire in fall 2010. Mental health was assessed with three psycho- metric scales: General Health Questionnaire 12 item version (GHQ-12), Perceived stress scale 4 item version (PSS-4) and Primary care PTSD (PC-PTSD). Multiple logistic regression was conducted to evaluate odds ratios (ORs) and 95% confidence intervals (CIs) of mental health by level of exposure. Results: Compared with the control group, high exposed participants had an overall increased risk of experiencing mental distress (OR 1.39; 95% CI 1.06 to 1.83. When comparing two exposed groups with regard to PTSD symptoms, the high exposure group had significantly increased risk of PTSD symptoms (OR 3.74; 95% CI 1.16 to 12.11). Findings also show that being directly exposed (e.g. property damage, feeling insec- ure as a result of the eruption, seeing volcano from home), had increased risk of psychological morbidity. Conclusions: In our 6-9 month follow-up of residents exposed to the Eyjafjallajokull volcanic eruption, high exposure was strongly associa- ted with an increase in mental distress compared to the control group. Future studies should thus aim at investigating long-term effects. E 137 BMP9/ALK1 boðleiðin ýtir undir æðaþelssérhæfingu stofnfrumna úr fósturvísum manna Anne Richter, Svala H. Magnús, Jóhann F. Rúnarsson, Guðrún Valdimarsdóttir Lífefna- og sameindalíffræðistofu, læknadeild Háskóla Íslands, gudrunva@hi.is Inngangur: Knockout músatilraunir hafa sýnt fram á nauðsyn Transforming growth factor beta (TGFbeta) fjölskyldunnar í þroskun hjarta- og æðakerfis. Stofnfrumur úr fósturvísum manna (hES frumur) eru gott líkan til að skoða sameindafræðilega ferla í fósturþroskun manna og orsakir æðasjúkdóma. TGFbeta viðtakinn ALK1 er sértækur fyrir æðaþelsfrumur. Bone Morphogenetic Protein 9 (BMP9) tilheyrir TGFbeta fjölskyldunni og binst ALK1 með hárri sækni en niðurstöður hafa bæði sýnt jákvæð/neikvæð áhrif BMP9 á æðamyndun (angioge- nesis) í æðaþelsfrumum. Markmið rannsóknarinnar var að athuga áhrif BMP9 vaxtarþáttarins á æðaþelssérhæfingu hES fruma. Efniviður og aðferðir: hES frumur voru sérhæfðar í æðaþelsfrumur með nýrri aðferð sem eykur miðlagssérhæfingu í upphafi. Frumur voru ræktaðar sem einþekja þegar meta átti gena- og próteintjáningu (qPCR/ WB) eða myndaðar frumukúlur (embryoid bodies) sem voru steyptar í kollagengel þegar meta átti sprotavöxt æðaþelsfrumna og ónæmislitanir framkvæmdar samhliða. Niðurstöður: BMP9 ýtir sterklega undir æðaþelssérhæfingu hES fruma og sprotavöxt út frá hES frumukúlum með virkjun á Smad1/5/8 og Id1 tjáningu. Hlutdeild ALK1 var athuguð með anti-hALK1 mótefni [PF- 03446962]. Í ljós kom að BMP9 örvaður sprotavöxtur æðaþelsfrumna var hindraður með anti-hALK1. Ályktanir: Við höfum notað hES frumur sem líkan til að líkja eftir þroskun æðaþels í mönnum. Við sýnum fram á að BMP9 stuðlar að æðaþelssérhæfingu hES frumna og sprotavexti út frá hES frumukúlum. BMP9 kemur þessum áhrifum áleiðis í gegnum ALK1 viðtakann sem virkjar Smad1/5/8 og eykur Id1 tjáningu. Við vonum að niðurstöður okkar geti leitt til nýrra lyfja fyrir sjúklinga sem þjást af æðasjúkdómum og jafnvel að koma í veg fyrir æðamyndun tengdri æxlisvexti. E 138 HER2 induced EMT and tumorigenicity in breast epithelial stem cells is inhibited by co-expression of EGFR Sævar Ingþórsson1,2, Kristin Andersen3, Bylgja Hilmarsdottir1,2, Gunhild Maelandsmo3, Magnús K. Magnússon1,2,4, Þórarinn Guðjónsson1,2 1Stem Cell Research Unit, Biomedical Center, Faculty of Medicine, University of Iceland, 2Department of Laboratory Haematology, Landspítali University Hospital, 3Department of Tumor Biology, Institute for cancer research, The Norwegian Radium Hospital, 4Department of Pharmacology and Toxicology, Faculty of Medicine, University of Iceland saevari@hi.is Introduction: The members of the EGFR kinase family are important players in breast morphogenesis and cancer. HER2 and EGFR express- ion has been shown to have prognostic value in certain subtypes of breast cancer such as, HER2- amplified, basal-like, and luminal type B. These subtypes are highly metastatic and enriched with cancer stem cells. Methods and data: D492 is a breast epithelial cell line with stem cell properties that generates luminal- and myoepithelial cells and forms elaborate branching structures in 3D culture. Methods used in this study include westen blotting, immunofluorescence three-dimensional cell culture and Real-Time PCR. Results: Here, we show that overexpression of HER2 in D492 (D492HER2) results in epithelial to mesenchymal transition (EMT) as evidenced by reduced expression of E-cadherin and keratins, gain of the mesenchy- mal markers such as N-cadherin and AXL and formation of grape or spindle-like structures in 3D culture. In contrast, overexpression of EGFR in D492 (D492EGFR) drives differentiation towards myoepithelial phenotype. When EGFR is overexpressed in D492HER2(D492HER2/EGFR), cells retain their EMT phenotype in monolayer culture. In contrast, in 3D culture,D492HER2/EGFRcells are reverted towards epithelial differen- tiation. When cells were injected into nude mice, D492HER2cells formed large tumors. In contrast D492HER2/EGFRcells formed smaller tumors with phenotype similar to cells in 3D culture. Conclusions: Our data indicate that in HER2 overexpressing D492 cells, EGFR can behave as a tumor suppressor, by maintaining epithelial differentiation.
Qupperneq 1
Qupperneq 2
Qupperneq 3
Qupperneq 4
Qupperneq 5
Qupperneq 6
Qupperneq 7
Qupperneq 8
Qupperneq 9
Qupperneq 10
Qupperneq 11
Qupperneq 12
Qupperneq 13
Qupperneq 14
Qupperneq 15
Qupperneq 16
Qupperneq 17
Qupperneq 18
Qupperneq 19
Qupperneq 20
Qupperneq 21
Qupperneq 22
Qupperneq 23
Qupperneq 24
Qupperneq 25
Qupperneq 26
Qupperneq 27
Qupperneq 28
Qupperneq 29
Qupperneq 30
Qupperneq 31
Qupperneq 32
Qupperneq 33
Qupperneq 34
Qupperneq 35
Qupperneq 36
Qupperneq 37
Qupperneq 38
Qupperneq 39
Qupperneq 40
Qupperneq 41
Qupperneq 42
Qupperneq 43
Qupperneq 44
Qupperneq 45
Qupperneq 46
Qupperneq 47
Qupperneq 48
Qupperneq 49
Qupperneq 50
Qupperneq 51
Qupperneq 52
Qupperneq 53
Qupperneq 54
Qupperneq 55
Qupperneq 56
Qupperneq 57
Qupperneq 58
Qupperneq 59
Qupperneq 60
Qupperneq 61
Qupperneq 62
Qupperneq 63
Qupperneq 64
Qupperneq 65
Qupperneq 66
Qupperneq 67
Qupperneq 68
Qupperneq 69
Qupperneq 70
Qupperneq 71
Qupperneq 72
Qupperneq 73
Qupperneq 74
Qupperneq 75
Qupperneq 76
Qupperneq 77
Qupperneq 78
Qupperneq 79
Qupperneq 80
Qupperneq 81
Qupperneq 82
Qupperneq 83
Qupperneq 84
Qupperneq 85
Qupperneq 86
Qupperneq 87
Qupperneq 88
Qupperneq 89
Qupperneq 90
Qupperneq 91
Qupperneq 92
Qupperneq 93
Qupperneq 94
Qupperneq 95
Qupperneq 96
Qupperneq 97
Qupperneq 98
Qupperneq 99
Qupperneq 100
Qupperneq 101
Qupperneq 102
Qupperneq 103
Qupperneq 104
Qupperneq 105
Qupperneq 106
Qupperneq 107
Qupperneq 108
Qupperneq 109
Qupperneq 110
Qupperneq 111
Qupperneq 112
Qupperneq 113
Qupperneq 114
Qupperneq 115
Qupperneq 116
Qupperneq 117
Qupperneq 118
Qupperneq 119
Qupperneq 120
Qupperneq 121
Qupperneq 122
Qupperneq 123
Qupperneq 124
Qupperneq 125
Qupperneq 126
Qupperneq 127
Qupperneq 128
Qupperneq 129
Qupperneq 130
Qupperneq 131
Qupperneq 132
Qupperneq 133
Qupperneq 134
Qupperneq 135
Qupperneq 136
Qupperneq 137
Qupperneq 138
Qupperneq 139
Qupperneq 140
Qupperneq 141
Qupperneq 142
Qupperneq 143
Qupperneq 144
Qupperneq 145
Qupperneq 146
Qupperneq 147
Qupperneq 148
Qupperneq 149
Qupperneq 150
Qupperneq 151
Qupperneq 152
Qupperneq 153
Qupperneq 154
Qupperneq 155
Qupperneq 156
Qupperneq 157
Qupperneq 158
Qupperneq 159
Qupperneq 160
Qupperneq 161
Qupperneq 162
Qupperneq 163
Qupperneq 164
Qupperneq 165
Qupperneq 166
Qupperneq 167
Qupperneq 168
Qupperneq 169
Qupperneq 170
Qupperneq 171
Qupperneq 172
Qupperneq 173

x

Læknablaðið : fylgirit

Direct Links

Hvis du vil linke til denne avis/magasin, skal du bruge disse links:

Link til denne avis/magasin: Læknablaðið : fylgirit
https://timarit.is/publication/991

Link til dette eksemplar:

Link til denne side:

Link til denne artikel:

Venligst ikke link direkte til billeder eller PDfs på Timarit.is, da sådanne webadresser kan ændres uden advarsel. Brug venligst de angivne webadresser for at linke til sitet.